389 related articles for article (PubMed ID: 20007378)
1. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.
Jura N; Shan Y; Cao X; Shaw DE; Kuriyan J
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21608-13. PubMed ID: 20007378
[TBL] [Abstract][Full Text] [Related]
2. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
Monsey J; Shen W; Schlesinger P; Bose R
J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations.
Littlefield P; Liu L; Mysore V; Shan Y; Shaw DE; Jura N
Sci Signal; 2014 Dec; 7(354):ra114. PubMed ID: 25468994
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.
Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J
Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415
[TBL] [Abstract][Full Text] [Related]
5. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation.
Shi F; Telesco SE; Liu Y; Radhakrishnan R; Lemmon MA
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7692-7. PubMed ID: 20351256
[TBL] [Abstract][Full Text] [Related]
6. Inter-lobe Motions Allosterically Regulate the Structure and Function of EGFR Kinase.
Moritsugu K; Nishino Y; Kidera A
J Mol Biol; 2020 Jul; 432(16):4561-4575. PubMed ID: 32534062
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.
Jura N; Endres NF; Engel K; Deindl S; Das R; Lamers MH; Wemmer DE; Zhang X; Kuriyan J
Cell; 2009 Jun; 137(7):1293-307. PubMed ID: 19563760
[TBL] [Abstract][Full Text] [Related]
8. Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
Jin P; Zhang J; Beryt M; Turin L; Brdlik C; Feng Y; Bai X; Liu J; Jorgensen B; Shepard HM
Mol Med; 2009; 15(1-2):11-20. PubMed ID: 19048033
[TBL] [Abstract][Full Text] [Related]
9. Transitions to catalytically inactive conformations in EGFR kinase.
Shan Y; Arkhipov A; Kim ET; Pan AC; Shaw DE
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7270-5. PubMed ID: 23576739
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.
Shih AJ; Telesco SE; Choi SH; Lemmon MA; Radhakrishnan R
Biochem J; 2011 Jun; 436(2):241-51. PubMed ID: 21426301
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Kinase Activity in the Caenorhabditis elegans EGF Receptor, LET-23.
Liu L; Thaker TM; Freed DM; Frazier N; Malhotra K; Lemmon MA; Jura N
Structure; 2018 Feb; 26(2):270-281.e4. PubMed ID: 29358026
[TBL] [Abstract][Full Text] [Related]
12. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family.
Arkhipov A; Shan Y; Kim ET; Dror RO; Shaw DE
Elife; 2013 Jul; 2():e00708. PubMed ID: 23878723
[TBL] [Abstract][Full Text] [Related]
13. HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways.
Choi BK; Cai X; Yuan B; Huang Z; Fan X; Deng H; Zhang N; An Z
Protein Cell; 2012 Oct; 3(10):781-9. PubMed ID: 22983903
[TBL] [Abstract][Full Text] [Related]
14. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
15. Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase.
Zhang H; Shen W; Rempel D; Monsey J; Vidavsky I; Gross ML; Bose R
Mol Cell Proteomics; 2011 Jun; 10(6):M110.005678. PubMed ID: 21422241
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics of the asymmetric dimers of EGFR: simulations on the active and inactive conformations of the kinase domain.
Songtawee N; Bevan DR; Choowongkomon K
J Mol Graph Model; 2015 May; 58():16-29. PubMed ID: 25805329
[TBL] [Abstract][Full Text] [Related]
17. Co-conserved features associated with cis regulation of ErbB tyrosine kinases.
Mirza A; Mustafa M; Talevich E; Kannan N
PLoS One; 2010 Dec; 5(12):e14310. PubMed ID: 21179209
[TBL] [Abstract][Full Text] [Related]
18. A single ligand is sufficient to activate EGFR dimers.
Liu P; Cleveland TE; Bouyain S; Byrne PO; Longo PA; Leahy DJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10861-6. PubMed ID: 22699492
[TBL] [Abstract][Full Text] [Related]
19. Carboxyl group footprinting mass spectrometry and molecular dynamics identify key interactions in the HER2-HER3 receptor tyrosine kinase interface.
Collier TS; Diraviyam K; Monsey J; Shen W; Sept D; Bose R
J Biol Chem; 2013 Aug; 288(35):25254-25264. PubMed ID: 23843458
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.
Aertgeerts K; Skene R; Yano J; Sang BC; Zou H; Snell G; Jennings A; Iwamoto K; Habuka N; Hirokawa A; Ishikawa T; Tanaka T; Miki H; Ohta Y; Sogabe S
J Biol Chem; 2011 May; 286(21):18756-65. PubMed ID: 21454582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
